MarketPulse

CVS Health

5 articles
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

CVS Health Signals Growth Momentum with Revenue and Profitability Boost

CVS Health announces positive developments expected to boost revenue and profitability, receiving strong industry reception and signaling renewed investor confidence in the healthcare company.
CVShealthcareprofitability
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

CVS Stock Eyes Dividend Appeal Despite Regulatory Headwinds

CVS Health navigates regulatory challenges while positive developments emerge, raising questions about dividend stock valuation amid industry pressures.
CVSdividend stockhealthcare stocks
The Motley FoolThe Motley Fool··Selena Maranjian

CVS Health's Modest Returns Mask Deeper Structural Challenges for Investors

$100 invested in $CVS five years ago grew to $108.11 (1.6% annually), trailing $SPX significantly while offering 3.62% dividend yield.
CVSS&P 500dividend yield
BenzingaBenzinga··Prnewswire

CVS Health Declares $0.665 Quarterly Dividend, Signaling Confidence in Cash Flow

CVS Health's board approved a $0.665 per share quarterly dividend, payable May 4, 2026, reflecting management's confidence in operational stability.
CVShealthcaredividend
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Healthcare Sector Poised for Growth as CVS and Vertex Eye Strategic Milestones

CVS and Vertex poised for growth through 2026 via operational improvements and expanded product pipelines. Both companies expected to deliver significant shareholder value.
CVSVRTXbiotechhealthcare stocks